Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders. | Behav Pharmacol;14(4): 257-77, 2003 Jul. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Insight into the function of Group I and Group II metabotropic glutamate (mGlu) receptors: behavioural characterization and implications for the treatment of CNS disorders.

Spooren, W; Ballard, T; Gasparini, F; Amalric, M; Mutel, V; Schreiber, R.

Affiliation

Spooren W; F. Hoffmann-La Roche, Pharma Research Basel Dsicovery--Neuroscience, Basel, Switzerland. will.spooren@roche.com

Behav Pharmacol ; 14(4): 257-77, 2003 Jul.

Article in En | MEDLINE | ID: mdl-12838033

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Brain / Brain Diseases / Receptors, Metabotropic Glutamate Limits: Animals Language: En Journal: Behav Pharmacol Journal subject: CIENCIAS DO COMPORTAMENTO / FARMACOLOGIA Year: 2003 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Brain / Brain Diseases / Receptors, Metabotropic Glutamate Limits: Animals Language: En Journal: Behav Pharmacol Journal subject: CIENCIAS DO COMPORTAMENTO / FARMACOLOGIA Year: 2003 Document type: Article Affiliation country: Country of publication: